Insider Trading: Celgene Corp (CELG.O)

CELG.O on Nasdaq

116.09USD
22 May 2015
Change (% chg)

$-0.11 (-0.09%)
Prev Close
$116.20
Open
$115.50
Day's High
$116.54
Day's Low
$114.92
Volume
2,651,131
Avg. Vol
5,300,717
52-wk High
$129.06
52-wk Low
$74.00

Search Stocks
Hugin Robert J Options Exercised: 242,419
Trade Date: Tuesday, 28 May 2013 Price: 42.39
Title: Chief Executive Officer Shares Held: 525,378
Type Traded: Direct Net Change in Shares This Filing: 68,086

Institutional Holders

% Shares Owned: 82.92%
# of Holders: 1,540
Total Shares Held: 657,639,346
3 Mo. Net Change: -8,933,133
# New Positions: 125
# Closed Positions: 72
# Increased Positions: 596
# Reduced Positions: 622
# Net Buyers: -26

Officers & Directors

Name Age Since Current Position

Robert Hugin

60 2014 Chairman of the Board, Chief Executive Officer

Mark Alles

56 2014 President, Chief Operating Officer

Thomas Daniel

61 2014 President, Research and Early Development

Peter Kellogg

59 2014 Chief Financial Officer, Executive Vice President

Jacqualyn Fouse

54 2014 President - Hematology & Oncology

Perry Karsen

60 2013 Chief Executive Officer of Celgene Cellular Therapeutics

Scott Smith

53 2014 President - Inflammation & Immunology

Lawrence Stein

65 2012 Executive Vice President, General Counsel, Corporate Secretary

Michael Casey

69 2007 Lead Independent Director

Michael Bonney

56 2015 Director

Richard Barker

66 2012 Independent Director

Carrie Cox

57 2009 Independent Director

Michael Friedman

71 2011 Independent Director

Gilla Kaplan

68 1998 Independent Director

James Loughlin

72 2007 Independent Director

Ernest Mario

76 2007 Independent Director
Search Stocks